<Record>
<Term>Taprizosin</Term>
<SemanticType>Pharmacologic Substance</SemanticType>
<ParentTerm>Vasodilating Agent</ParentTerm>
<ClassificationPath>Chemicals_and_Drugs_Kind/Drug, Food, Chemical or Biomedical Material/Pharmacologic Substance/Adjuvant/Vasodilating Agent/Taprizosin,/NCIThesaurus/Chemicals_and_Drugs_Kind/Drug, Food, Chemical or Biomedical Material/Pharmacologic Substance/Adjuvant/Adrenergic Agent/Adrenergic Antagonist/Alpha-Adrenergic Antagonist/Taprizosin</ClassificationPath>
<BroaderTerm>Taprizosin,</BroaderTerm>
<BroaderTerm>Taprizosin</BroaderTerm>
<BroaderTerm>Chemicals_and_Drugs_Kind</BroaderTerm>
<BroaderTerm>Adrenergic Antagonist</BroaderTerm>
<BroaderTerm>Vasodilating Agent</BroaderTerm>
<BroaderTerm>NCIThesaurus</BroaderTerm>
<BroaderTerm>Pharmacologic Substance</BroaderTerm>
<BroaderTerm>Adjuvant</BroaderTerm>
<BroaderTerm>Alpha-Adrenergic Antagonist</BroaderTerm>
<BroaderTerm>Adrenergic Agent</BroaderTerm>
<BroaderTerm>Drug, Food, Chemical or Biomedical Material</BroaderTerm>
<Synonym>N-{2-(4-Amino-6,7-dimethoxy-5-(2-pyridyl)quinazolin-2-yl)-1,2,3,4-tetrahydro-5-isoquinolyl}methanesulfonamide</Synonym>
<Synonym>TAPRIZOSIN</Synonym>
<Synonym>Taprizosin</Synonym>
<Source>NCI Thesaurus</Source>
</Record>
